Significant bacteriuria among asymptomatic antenatal clinic attendees in Ibadan, Nigeria

listen audio

Study Justification:
– Untreated asymptomatic bacteriuria can lead to urinary tract infection (UTI) in pregnancy with devastating maternal and neonatal effects.
– The prevalence of significant bacteriuria among asymptomatic antenatal clinic attendees in Ibadan, Nigeria is unknown.
– This study aimed to determine the prevalence of significant bacteriuria and provide insights into the demographic and clinical factors associated with it.
Study Highlights:
– The study was conducted over a two-year period (April 2007 to March 2009) at two antenatal clinics in Ibadan, Nigeria.
– A total of 473 asymptomatic antenatal clinic attendees were enrolled in the study.
– Urine specimens were collected and examined microscopically for white blood cells, red blood cells, and bacteria.
– The specimens were cultured on MacConkey agar to determine the presence of significant bacteriuria.
– The prevalence of significant bacteriuria among the study population was found to be 28.8%.
– The highest prevalence was observed in the 25-29 year age group.
– There was no statistically significant association between significant bacteriuria and education level or previous history of abortion.
– The majority of subjects with significant bacteriuria presented in the second trimester of pregnancy.
Recommendations for Lay Reader:
– Pregnant women should be encouraged to access antenatal care services early in pregnancy to detect and treat asymptomatic bacteriuria.
– Regular urine screening should be conducted during antenatal visits to identify and treat significant bacteriuria.
– Education on the importance of early detection and treatment of asymptomatic bacteriuria should be provided to pregnant women.
Recommendations for Policy Maker:
– Advocacy programs should be initiated to promote early access to antenatal care services among pregnant women.
– Health care facilities should incorporate regular urine screening for significant bacteriuria as part of routine antenatal care.
– Resources should be allocated to train health care providers on the detection and management of asymptomatic bacteriuria in pregnancy.
Key Role Players:
– Researchers and scientists involved in conducting the study
– Health care providers at antenatal clinics
– Policy makers and government officials responsible for implementing and funding health care programs
Cost Items for Planning Recommendations:
– Training programs for health care providers on the detection and management of asymptomatic bacteriuria
– Development and distribution of educational materials for pregnant women
– Implementation of regular urine screening programs at antenatal clinics
– Monitoring and evaluation of the effectiveness of advocacy programs and urine screening initiatives

The strength of evidence for this abstract is 7 out of 10.
The evidence in the abstract is moderately strong. The study is a two-year cross-sectional epidemiological study conducted at two antenatal clinics in Ibadan, Nigeria. The study included a relatively large sample size of 473 subjects and used standardized methods for data collection and analysis. The prevalence rate of significant bacteriuria among asymptomatic antenatal clinic attendees was reported at 28.8%. However, the abstract lacks information on the representativeness of the study population and the generalizability of the findings. Additionally, the statistical significance of some associations mentioned in the abstract is not provided. To improve the strength of the evidence, future studies could consider including a more diverse study population and providing more detailed information on the statistical analysis and the implications of the findings.

Untreated asymptomatic bacteriuria can lead to urinary tract infection (UTI) in pregnancy with devastating maternal and neonatal effects such as prematurity and low birth weight, higher fetal mortality rates and significant maternal morbidity. We carried out a two year (April 2007 to March 2009) cross-sectional epidemiological study to determine the prevalence of significant bacteriuria among asymptomatic antenatal clinic attendees at two antenatal clinics (ANCs) in University College Hospital and Adeoyo Maternity Hospital, both in Ibadan, Nigeria. All consenting ANC attendees without UTI were enrolled in the study. Urine specimens of 5 to 10 ml collected from each subject were examined microscopically for white blood cells, red blood cells and bacteria. The specimens were further cultured on MacConkey agar using a sterile bacteriological loop that delivered 0.002 ml of urine. Colony counts yielding bacterial growth of more than 105/ml of pure isolates were considered significant. Of the 473 subjects studied, 136 had significant bacteriuria, giving a prevalence rate of 28.8%. The highest age specific prevalence (47.8%) was found in the 25-29 year olds while only one (0.7%) was found in the teenage group. A large percentage (64.0%) of subjects with significant bacteriuria had tertiary education, compared with 4.4% who had no formal education but the association was not statistically significant (X2 = 0.47, p = 0.79). The majority (75.8%) of subjects with significant bacteriuria had no previous history of abortion, while 20 (14.7%) had one previous abortion and only three (2.1%) admitted to three previous abortions (X2 = 5.16, p = 0.16). The majority (69.8%) of those with significant bacteriuria presented at second trimester while 38 (28.0%) presented at third trimester (X2 = 6.5, p = 37). Only 22 (4.6%) of the studied subjects presented at first trimester, and 3 (13.7%) of these had significant bacteriuria. The prevalence of asymptomatic bacteriuria is high among this study population. Hence we suggest that advocacy programs be initiated to urge pregnant women to access ANC services early in pregnancy. © 2011 by The Japanese Society of Tropical Medicine.

This two-year (April 2007 to March 2009) cross-sectional epidemiological study was carried out at two ANCs in Ibadan, Nigeria. These ANCs were the University College Hospital (UCH), a tertiary health care centre, and Adeoyo Maternity Hospital (AMH), a secondary health care facility. The two hospitals serve as health care facilities for middle and upper class patients in the population. Ethical approval was obtained from the University of Ibadan/UCH Joint Ethical Committee prior to recruitment of participants. Ante Natal Clinic attendees without dysuria, frequency and urgency of urination or other clinical symptoms of UTI were interviewed. Subjects who gave informed consent were enrolled into the study while those who refused participation were excluded. A standardized questionnaire was used to obtain demographic data, medical and social information as well as the gynaecological and obstetric history of the subjects. Subjects with gestational diabetes were excluded from the study because they are more prone to UTI, especially significant bacteriuria without pyuria [2]. A well-labelled sterile universal container was given to each participant to collect about 5–10 ml of mid-stream urine. The specimen was promptly transported to the Department of Medical Microbiology and Parasitology, UCH, Ibadan for immediate processing. One drop of un-centrifuged urine was aseptically placed on a clean grease- free well- labelled frosted slide and covered with a slip. It was then examined under a microscope using ×10 eye objective lens looking for white blood cells, red blood cells, yeast cells and various types of casts. This procedure was repeated using sediment obtained from about 10 ml of centrifuged urine. All the urine specimens were cultured on MacConkey agar to test for significant bacteriuria. The approximate number of bacteria per ml of un-centrifuged urine was estimated using a sterile special calibrated wire loop (that can hold 1/500 ml i.e 0.002 ml of urine) for inoculation on sterile culture medium and incubated aerobically at 35°C to 37°C for 24–48 hours. The number of isolated colonies (colony forming units) on MacConkey medium was counted using a counting chamber and was then multiplied by a factor of 500 to estimate significant bacteriuria. A count more than 105 per ml of urine was taken as significant bacteriuria; less than 104 per ml was taken as not significant while counts between 104–105 per ml were considered doubtful and the urine samples were re-examined. The computer data were studied using the statistical software SPSS version 10.0 (SPSS InC, Chicago, IL). Data exploration was done by examining the frequency of distribution of all the variables. Results were presented in the form of tables and charts. Chi square test was applied where necessary. Statistical significance was set at p < 0.05.

N/A

Based on the provided information, here are some potential innovations that can be used to improve access to maternal health:

1. Mobile Clinics: Implementing mobile clinics that can travel to remote areas or underserved communities to provide antenatal care and screening for asymptomatic bacteriuria. This can help reach pregnant women who may have limited access to healthcare facilities.

2. Telemedicine: Introducing telemedicine services that allow pregnant women to consult with healthcare professionals remotely. This can provide access to medical advice and guidance, reducing the need for physical visits to healthcare facilities.

3. Health Education Programs: Developing advocacy programs and health education campaigns to raise awareness about the importance of early access to antenatal care. This can help pregnant women understand the risks of untreated asymptomatic bacteriuria and encourage them to seek healthcare services early in their pregnancy.

4. Community Health Workers: Training and deploying community health workers to provide basic antenatal care services, including screening for asymptomatic bacteriuria, in underserved areas. This can help bridge the gap between healthcare facilities and pregnant women who may have limited mobility or resources.

5. Improved Testing Methods: Exploring and implementing more efficient and cost-effective testing methods for significant bacteriuria, such as rapid diagnostic tests or point-of-care testing. This can help streamline the screening process and ensure timely detection and treatment of asymptomatic bacteriuria.

6. Collaboration and Partnerships: Establishing partnerships between healthcare facilities, government agencies, and non-profit organizations to improve access to maternal health services. This can involve sharing resources, expertise, and funding to expand and enhance existing healthcare infrastructure.

It is important to note that these recommendations are general and may need to be tailored to the specific context and needs of the population in Ibadan, Nigeria.
AI Innovations Description
The recommendation from the study to improve access to maternal health is to initiate advocacy programs that encourage pregnant women to access antenatal care (ANC) services early in pregnancy. This is based on the finding that the prevalence of asymptomatic bacteriuria, which can lead to urinary tract infections and adverse maternal and neonatal outcomes, is high among the study population. By promoting early access to ANC services, pregnant women can receive timely screening and treatment for asymptomatic bacteriuria, reducing the risk of complications.
AI Innovations Methodology
Based on the provided information, here are some potential recommendations to improve access to maternal health:

1. Increase awareness and education: Implement advocacy programs to educate pregnant women about the importance of accessing antenatal care services early in pregnancy. This can be done through community outreach programs, health campaigns, and partnerships with local organizations.

2. Strengthen healthcare infrastructure: Improve the availability and accessibility of antenatal clinics by investing in healthcare infrastructure, including the establishment of more clinics in underserved areas. This can help reduce travel distances and waiting times for pregnant women seeking care.

3. Train healthcare providers: Provide training and capacity building programs for healthcare providers, particularly in areas with high prevalence of significant bacteriuria. This can enhance their knowledge and skills in diagnosing and managing asymptomatic bacteriuria, leading to improved maternal health outcomes.

4. Implement screening protocols: Develop and implement standardized screening protocols for asymptomatic bacteriuria during antenatal visits. This can help identify and treat cases early, reducing the risk of complications such as urinary tract infections and adverse pregnancy outcomes.

To simulate the impact of these recommendations on improving access to maternal health, a methodology could be developed as follows:

1. Define the target population: Determine the specific population that will be affected by the recommendations, such as pregnant women attending antenatal clinics in Ibadan, Nigeria.

2. Collect baseline data: Gather data on the current access to maternal health services, including the prevalence of significant bacteriuria among asymptomatic antenatal clinic attendees, as well as demographic and socio-economic factors that may influence access.

3. Develop a simulation model: Create a simulation model that incorporates the recommendations and their potential impact on access to maternal health. This model should consider factors such as the number of additional clinics established, the increase in awareness and education, the training of healthcare providers, and the implementation of screening protocols.

4. Input data and run simulations: Input the baseline data into the simulation model and run multiple simulations to assess the potential impact of the recommendations. This can include estimating changes in the prevalence of significant bacteriuria, improvements in access to antenatal care services, and potential reductions in adverse maternal and neonatal outcomes.

5. Analyze results: Analyze the results of the simulations to determine the effectiveness of the recommendations in improving access to maternal health. This can include evaluating the magnitude of the impact, identifying any potential challenges or limitations, and assessing the cost-effectiveness of the interventions.

6. Refine and validate the model: Refine the simulation model based on the analysis of the results and validate it using additional data or expert input. This can help ensure the accuracy and reliability of the model for future use.

By following this methodology, policymakers and healthcare stakeholders can gain insights into the potential impact of the recommendations on improving access to maternal health and make informed decisions on implementing these interventions.

Share this:
Facebook
Twitter
LinkedIn
WhatsApp
Email